<?properties open_access?>
<?subarticle pcbi.1008607.r001?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS Comput Biol</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-id journal-id-type="pmc">ploscomp</journal-id>
    <journal-title-group>
      <journal-title>PLoS Computational Biology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1553-734X</issn>
    <issn pub-type="epub">1553-7358</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7861515</article-id>
    <article-id pub-id-type="pmid">33493161</article-id>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1008607</article-id>
    <article-id pub-id-type="publisher-id">PCOMPBIOL-D-20-01304</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Physiology</subject>
          <subj-group>
            <subject>Immune Physiology</subject>
            <subj-group>
              <subject>Antibodies</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune System Proteins</subject>
            <subj-group>
              <subject>Antibodies</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune System Proteins</subject>
            <subj-group>
              <subject>Antibodies</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Proteins</subject>
            <subj-group>
              <subject>Immune System Proteins</subject>
              <subj-group>
                <subject>Antibodies</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Database and Informatics Methods</subject>
          <subj-group>
            <subject>Biological Databases</subject>
            <subj-group>
              <subject>Proteomic Databases</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Proteomics</subject>
            <subj-group>
              <subject>Proteomic Databases</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Molecular biology</subject>
          <subj-group>
            <subject>Molecular biology techniques</subject>
            <subj-group>
              <subject>Sequencing techniques</subject>
              <subj-group>
                <subject>DNA sequencing</subject>
                <subj-group>
                  <subject>Next-Generation Sequencing</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and analysis methods</subject>
        <subj-group>
          <subject>Molecular biology techniques</subject>
          <subj-group>
            <subject>Sequencing techniques</subject>
            <subj-group>
              <subject>DNA sequencing</subject>
              <subj-group>
                <subject>Next-Generation Sequencing</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Computational Biology</subject>
          <subj-group>
            <subject>Genome Analysis</subject>
            <subj-group>
              <subject>Transcriptome Analysis</subject>
              <subj-group>
                <subject>Next-Generation Sequencing</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Genomics</subject>
            <subj-group>
              <subject>Genome Analysis</subject>
              <subj-group>
                <subject>Transcriptome Analysis</subject>
                <subj-group>
                  <subject>Next-Generation Sequencing</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Proteomics</subject>
            <subj-group>
              <subject>Peptide Mapping</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Database and Informatics Methods</subject>
          <subj-group>
            <subject>Biological Databases</subject>
            <subj-group>
              <subject>Sequence Databases</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Database and Informatics Methods</subject>
          <subj-group>
            <subject>Bioinformatics</subject>
            <subj-group>
              <subject>Sequence Analysis</subject>
              <subj-group>
                <subject>Sequence Databases</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Physiology</subject>
          <subj-group>
            <subject>Immune Physiology</subject>
            <subj-group>
              <subject>Antigens</subject>
              <subj-group>
                <subject>Antigen Isotypes</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune System Proteins</subject>
            <subj-group>
              <subject>Antigens</subject>
              <subj-group>
                <subject>Antigen Isotypes</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immune System Proteins</subject>
            <subj-group>
              <subject>Antigens</subject>
              <subj-group>
                <subject>Antigen Isotypes</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Proteins</subject>
            <subj-group>
              <subject>Immune System Proteins</subject>
              <subj-group>
                <subject>Antigens</subject>
                <subj-group>
                  <subject>Antigen Isotypes</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Molecular Biology</subject>
          <subj-group>
            <subject>Molecular Biology Techniques</subject>
            <subj-group>
              <subject>Cloning</subject>
              <subj-group>
                <subject>Molecular Cloning</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Molecular Biology Techniques</subject>
          <subj-group>
            <subject>Cloning</subject>
            <subj-group>
              <subject>Molecular Cloning</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Separation Processes</subject>
          <subj-group>
            <subject>Elution</subject>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>PASA: Proteomic analysis of serum antibodies web server</article-title>
      <alt-title alt-title-type="running-head">Proteomic analysis web server</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" equal-contrib="yes">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1984-2139</contrib-id>
        <name>
          <surname>Avram</surname>
          <given-names>Oren</given-names>
        </name>
        <role content-type="https://casrai.org/credit/">Conceptualization</role>
        <role content-type="https://casrai.org/credit/">Data curation</role>
        <role content-type="https://casrai.org/credit/">Formal analysis</role>
        <role content-type="https://casrai.org/credit/">Investigation</role>
        <role content-type="https://casrai.org/credit/">Methodology</role>
        <role content-type="https://casrai.org/credit/">Software</role>
        <role content-type="https://casrai.org/credit/">Validation</role>
        <role content-type="https://casrai.org/credit/">Visualization</role>
        <role content-type="https://casrai.org/credit/">Writing – original draft</role>
        <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
        <xref ref-type="aff" rid="aff001"/>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Kigel</surname>
          <given-names>Aya</given-names>
        </name>
        <role content-type="https://casrai.org/credit/">Conceptualization</role>
        <role content-type="https://casrai.org/credit/">Data curation</role>
        <role content-type="https://casrai.org/credit/">Formal analysis</role>
        <role content-type="https://casrai.org/credit/">Investigation</role>
        <role content-type="https://casrai.org/credit/">Validation</role>
        <xref ref-type="aff" rid="aff001"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4059-1047</contrib-id>
        <name>
          <surname>Vaisman-Mentesh</surname>
          <given-names>Anna</given-names>
        </name>
        <role content-type="https://casrai.org/credit/">Formal analysis</role>
        <role content-type="https://casrai.org/credit/">Investigation</role>
        <xref ref-type="aff" rid="aff001"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5938-8204</contrib-id>
        <name>
          <surname>Kligsberg</surname>
          <given-names>Sharon</given-names>
        </name>
        <role content-type="https://casrai.org/credit/">Data curation</role>
        <role content-type="https://casrai.org/credit/">Methodology</role>
        <role content-type="https://casrai.org/credit/">Software</role>
        <xref ref-type="aff" rid="aff001"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Rosenstein</surname>
          <given-names>Shai</given-names>
        </name>
        <role content-type="https://casrai.org/credit/">Investigation</role>
        <xref ref-type="aff" rid="aff001"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Dror</surname>
          <given-names>Yael</given-names>
        </name>
        <role content-type="https://casrai.org/credit/">Investigation</role>
        <xref ref-type="aff" rid="aff001"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9463-2575</contrib-id>
        <name>
          <surname>Pupko</surname>
          <given-names>Tal</given-names>
        </name>
        <role content-type="https://casrai.org/credit/">Conceptualization</role>
        <role content-type="https://casrai.org/credit/">Investigation</role>
        <role content-type="https://casrai.org/credit/">Methodology</role>
        <role content-type="https://casrai.org/credit/">Supervision</role>
        <role content-type="https://casrai.org/credit/">Writing – original draft</role>
        <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
        <xref ref-type="aff" rid="aff001"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5767-9059</contrib-id>
        <name>
          <surname>Wine</surname>
          <given-names>Yariv</given-names>
        </name>
        <role content-type="https://casrai.org/credit/">Conceptualization</role>
        <role content-type="https://casrai.org/credit/">Data curation</role>
        <role content-type="https://casrai.org/credit/">Formal analysis</role>
        <role content-type="https://casrai.org/credit/">Funding acquisition</role>
        <role content-type="https://casrai.org/credit/">Investigation</role>
        <role content-type="https://casrai.org/credit/">Methodology</role>
        <role content-type="https://casrai.org/credit/">Project administration</role>
        <role content-type="https://casrai.org/credit/">Resources</role>
        <role content-type="https://casrai.org/credit/">Supervision</role>
        <role content-type="https://casrai.org/credit/">Validation</role>
        <role content-type="https://casrai.org/credit/">Writing – original draft</role>
        <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
        <xref ref-type="aff" rid="aff001"/>
        <xref ref-type="corresp" rid="cor001">*</xref>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <addr-line>The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Pertea</surname>
          <given-names>Mihaela</given-names>
        </name>
        <role>Editor</role>
        <xref ref-type="aff" rid="edit1"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>Johns Hopkins University, UNITED STATES</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p>The authors have declared that no competing interests exist.</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>YarivWine@tauex.tau.ac.il</email></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>25</day>
      <month>1</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="collection">
      <month>1</month>
      <year>2021</year>
    </pub-date>
    <volume>17</volume>
    <issue>1</issue>
    <elocation-id>e1008607</elocation-id>
    <history>
      <date date-type="received">
        <day>22</day>
        <month>7</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>6</day>
        <month>12</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2021 Avram et al</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Avram et al</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="pcbi.1008607.pdf"/>
    <abstract>
      <sec id="sec001">
        <title>Motivation</title>
        <p>A comprehensive characterization of the humoral response towards a specific antigen requires quantification of the B-cell receptor repertoire by next-generation sequencing (BCR-Seq), as well as the analysis of serum antibodies against this antigen, using proteomics. The proteomic analysis is challenging since it necessitates the mapping of antigen-specific peptides to individual B-cell clones.</p>
      </sec>
      <sec id="sec002">
        <title>Results</title>
        <p>The PASA web server provides a robust computational platform for the analysis and integration of data obtained from proteomics of serum antibodies. PASA maps peptides derived from antibodies raised against a specific antigen to corresponding antibody sequences. It then analyzes and integrates proteomics and BCR-Seq data, thus providing a comprehensive characterization of the humoral response. The PASA web server is freely available at <ext-link ext-link-type="uri" xlink:href="https://pasa.tau.ac.il">https://pasa.tau.ac.il</ext-link> and open to all users without a login requirement.</p>
      </sec>
    </abstract>
    <abstract abstract-type="summary">
      <title>Author summary</title>
      <p>The proteomics of serum antibodies (Ig-Seq) is based on a two-arm foundation: the generation of BCR-Seq (using next-generation sequencing of B cells) and high-resolution mass-spectrometry (LC-MS/MS) of serum antibodies. The BCR-Seq data are used for the interpretation of mass-spectra and result in the identification of antibody derived peptides thus, the identification of V genes of the serum antibodies. To provide accessibility to non-expert users we introduce the PASA (Proteomic Analysis of Serum Antibodies) web server that provides a robust computational platform for the analysis and integration of data obtained from proteomics of serum antibodies and enables its integration with BCR-Seq data as obtained from ASAP (that provides bioinformatics support for BCR-Seq analysis and also provides as output a reference database that can be used in proteomic analysis of serum antibodies. ASAP is available at <ext-link ext-link-type="uri" xlink:href="http://asap.tau.ac.il">http://asap.tau.ac.il</ext-link>. PASA has a user-friendly interface, while it keeps the ability of expert users to tune their computations towards their special needs. We provide a GALLERY section that demonstrates selected outputs of PASA and example data to allow a quick ramp up for new users. Our graphical outputs promote quantitative analyses and visualization of the immune repertoires.</p>
    </abstract>
    <funding-group>
      <award-group id="award001">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003977</institution-id>
            <institution>Israel Science Foundation</institution>
          </institution-wrap>
        </funding-source>
        <award-id>1282/17</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5767-9059</contrib-id>
          <name>
            <surname>Wine</surname>
            <given-names>Yariv</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award002">
        <funding-source>
          <institution>Dalia and Eli Hurvits foundation</institution>
        </funding-source>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1984-2139</contrib-id>
          <name>
            <surname>Avram</surname>
            <given-names>Oren</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award003">
        <funding-source>
          <institution>Edmond J. Safra Center for Bioinformatics</institution>
        </funding-source>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1984-2139</contrib-id>
          <name>
            <surname>Avram</surname>
            <given-names>Oren</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <funding-statement>Y.W. funded by Israel Science Foundation (ISF) #1282/17 Yariv Wine, isf.org.il O.A. was supported in part by the Dalia and Eli Hurvits foundation and by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="1"/>
      <table-count count="0"/>
      <page-count count="5"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>PLOS Publication Stage</meta-name>
        <meta-value>vor-update-to-uncorrected-proof</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>Publication Update</meta-name>
        <meta-value>2021-02-04</meta-value>
      </custom-meta>
      <custom-meta id="data-availability">
        <meta-name>Data Availability</meta-name>
        <meta-value>Availability and implementation: PASA is freely available for noncommercial users as a web server at <ext-link ext-link-type="uri" xlink:href="https://pasa.tau.ac.il">https://pasa.tau.ac.il</ext-link>. The source code of this project is written in Python and is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/orenavram/PASA">https://github.com/orenavram/PASA</ext-link>.</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <title>Data Availability</title>
    <p>Availability and implementation: PASA is freely available for noncommercial users as a web server at <ext-link ext-link-type="uri" xlink:href="https://pasa.tau.ac.il">https://pasa.tau.ac.il</ext-link>. The source code of this project is written in Python and is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/orenavram/PASA">https://github.com/orenavram/PASA</ext-link>.</p>
  </notes>
</front>
<body>
  <disp-quote>
    <p>This is a <italic>PLOS Computational Biology</italic> Software paper.</p>
  </disp-quote>
  <sec sec-type="intro" id="sec003">
    <title>Introduction</title>
    <p>The hallmark of the adaptive immune response is based on its ability to generate an enormous diversity of different monoclonal antibodies mainly by chromosomal rearrangement, somatic hypermutation (SHM), and class-switch recombination. Antibody diversity occurs within the variable regions of the heavy and light chains (V<sub>H</sub> and V<sub>L</sub>, respectively), with the highest diversity in the complementary determining region 3 of the heavy chain (CDRH3) [<xref rid="pcbi.1008607.ref001" ref-type="bibr">1</xref>,<xref rid="pcbi.1008607.ref002" ref-type="bibr">2</xref>]. CDRH3 is often used as a unique identifier to determine antibody clonality [<xref rid="pcbi.1008607.ref003" ref-type="bibr">3</xref>,<xref rid="pcbi.1008607.ref004" ref-type="bibr">4</xref>]. Next-generation sequencing (NGS) of B cell receptors (BCR-Seq) revolutionized our ability to capture the diversity of antibodies at the highest resolution and helped address important immunological questions related to the development of the adaptive immune response in health and disease [<xref rid="pcbi.1008607.ref004" ref-type="bibr">4</xref>,<xref rid="pcbi.1008607.ref005" ref-type="bibr">5</xref>]. We and others have previously developed computational tools for analyzing the massive NGS data [<xref rid="pcbi.1008607.ref006" ref-type="bibr">6</xref>,<xref rid="pcbi.1008607.ref007" ref-type="bibr">7</xref>] that are <italic>continuously being</italic> accumulated in the The Adaptive Immune Receptor Repertoire (AIRR) distributed repository for public use [<xref rid="pcbi.1008607.ref008" ref-type="bibr">8</xref>]. However, BCR-Seq alone does not reveal the identity, relative concentration, and clonality of antigen-specific antibodies in the blood and/or secretions. Such data are highly important in order to address fundamental immunological questions and to institute a comprehensive immunome map [<xref rid="pcbi.1008607.ref009" ref-type="bibr">9</xref>]. This knowledge gap can be approached by using high-resolution shotgun tandem mass-spectrometry (LC-MS/MS, Ig-Seq) [<xref rid="pcbi.1008607.ref002" ref-type="bibr">2</xref>,<xref rid="pcbi.1008607.ref010" ref-type="bibr">10</xref>,<xref rid="pcbi.1008607.ref011" ref-type="bibr">11</xref>]. Since its establishment [<xref rid="pcbi.1008607.ref002" ref-type="bibr">2</xref>], Ig-Seq has opened new research avenues that yielded invaluable insights regarding the development of the immune response during disease and following vaccination [<xref rid="pcbi.1008607.ref012" ref-type="bibr">12</xref>–<xref rid="pcbi.1008607.ref017" ref-type="bibr">17</xref>]. The proteomic deconvolution of serum antibodies is challenging due to the extensive antibody diversification resulting from chromosomal rearrangements and SHM, which makes the mapping of obtained antibody-derived peptides to antibody germline sequences irrelevant. Therefore, obtaining the reference BCR-Seq database for each individual is a prerequisite for analyzing LC-MS/MS antibody datasets. Here, we developed PASA, an integrative approach that combines NGS with serum-antibody proteomics (derived from either human or murine), which allows mapping, analysis, and integration of peptides data with reference to individual-specific BCR-Seq data.</p>
    <sec id="sec004">
      <title>Design and <italic>implementation</italic></title>
      <p>The PASA web server is schematically illustrated in <xref ref-type="fig" rid="pcbi.1008607.g001">Fig 1</xref>. The input of PASA is: (1) BCR-Seq data, as obtained from ASAP [<xref rid="pcbi.1008607.ref006" ref-type="bibr">6</xref>]; (2) The raw mass spectrometry data files as obtained from LC-MS/MS [<xref rid="pcbi.1008607.ref011" ref-type="bibr">11</xref>,<xref rid="pcbi.1008607.ref015" ref-type="bibr">15</xref>]; (3) As part of the advanced options, the user can specify the digestion enzyme used to proteolytically cleave the antibodies (by default, Trypsin). Instead of (2), the user can provide a file of derived peptides obtained using MaxQuant [<xref rid="pcbi.1008607.ref018" ref-type="bibr">18</xref>,<xref rid="pcbi.1008607.ref019" ref-type="bibr">19</xref>]. As part of the proteomics experiments, antigen-specific antibodies are enriched by affinity chromatography against a given antigen. The enriched fraction is called “elution” and the depleted fraction is called “flow-through”. Peptides that are enriched in the elution fraction compared to the flow-through are considered antigen-specific. In order to use label-free quantification (LFQ) as implemented in MaxQuant, PASA requires at least two replicates for each affinity chromatography fraction. Example input files are provided in the web server. PASA’s running time may vary as it depends on the number of replicates and databases used. For instance, the analysis of the example input files (elution and flow-through triplicates, each triplicate of size ~6GB, together with three V gene sequence database, each of size 35 MB) took less than three hrs. If a user runs MaxQuant as stand-alone (i.e., not via PASA) and submits to PASA the output peptides list (instead of the raw mass spectrometry data files), the running time was dramatically reduced to no more than a few minutes (using the example V gene sequence database).</p>
      <fig id="pcbi.1008607.g001" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1008607.g001</object-id>
        <label>Fig 1</label>
        <caption>
          <title>PASA web server.</title>
          <p>PASA accepts (two or more) zipped proteomics spectral files in raw format. For the integration of data derived from NGS with data of antibody encoding B cells, the user is requested to upload V gene sequence database at the amino acid level. Our methodology is divided into two parts. The first part utilizes MaxQuant [<xref rid="pcbi.1008607.ref018" ref-type="bibr">18</xref>,<xref rid="pcbi.1008607.ref019" ref-type="bibr">19</xref>] to identify the sequences of peptides derived from antigen-specific serum antibodies. In the second part, mapped serum antibodies are analyzed to provide repertoire measurements and integrated with BCR-Seq data to establish a comprehensive immune map of the antibody response.</p>
        </caption>
        <graphic xlink:href="pcbi.1008607.g001"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="results" id="sec005">
    <title>Results</title>
    <p>The first step of PASA concerns the analysis of peptides derived from proteomics of serum antibodies. Specifically, PASA provides: (1) A list of peptides and their intensities for each fraction (elution and flow-through), as identified by MaxQuant; (2) The list of peptides that are enriched in the elution relative to the flow-through (by default, over five-fold relative intensity). These peptides correspond to antibodies that are antigen-specific; (3) The mapping of each antigen-specific peptide to the BCR-Seq database. This mapping provides a correspondence between a serum antibody and an antibody clone as found in the BCR-Seq data. Specifically, for some peptides no mapping is found, some map to more than one antibody clone, and some, which we call “informative peptides”, are mapped uniquely to a single antibody clone. Informative antigen-specific peptides can be mapped to CDRH3 or to other V gene regions. Peptides that are antigen-specific, informative, and are mapped to CDRH3 are of high interest since they provide a clear link between a secreted antibody to its corresponding antibody clone as found in BCR-Seq data. In the second step of PASA the antibody clones found in the first step are characterized. Specifically, PASA provides the following information: Isotype distribution (pie chart); CDR3 length distribution (bar plot); V, D, J gene usage (bar plots); VD, VJ, DJ, VDJ combined usage (bar plots); Proteomics intensity with respect to each antibody sequence frequency as observed in the BCR-seq database. For the sake of convenience, the web server includes Gallery and Overview sections, together with a running example.</p>
    <sec id="sec006">
      <title>Availability and future directions</title>
      <p>PASA is freely available for noncommercial users as a web server at <ext-link ext-link-type="uri" xlink:href="https://pasa.tau.ac.il">https://pasa.tau.ac.il</ext-link> and as a command line application as well. The source code of PASA is written in Python and is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/orenavram/PASA">https://github.com/orenavram/PASA</ext-link>. Joint analysis of Ig-Seq and BCR-Seq provides invaluable insights regarding serum antibody dynamics against a specific antigen. For example, it allows analyzing longitudinal changes in antibody dynamics, studying the affinity maturation of an antibody clone towards a specific antigen, and provides an overall comprehensive map of the humoral immune response following vaccine, disease, or at health. PASA is a user-friendly platform that provides expert and non-expert users with the ability to tune their computations towards their special experimental needs. In the follow-up developments we plan to add advance analysis tools including the ability to analyze experimental data derived from other species and various V gene sequence database.</p>
    </sec>
  </sec>
</body>
<back>
  <ref-list>
    <title>References</title>
    <ref id="pcbi.1008607.ref001">
      <label>1</label>
      <mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>JL</given-names></name>, <name><surname>Davis</surname><given-names>MM</given-names></name>. <article-title>Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities</article-title>. <source>Immunity</source>. <year>2000</year>;<volume>13</volume>(<issue>1</issue>):<fpage>37</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/s1074-7613(00)00006-6</pub-id> .<?supplied-pmid 10933393?><pub-id pub-id-type="pmid">10933393</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Wine</surname><given-names>Y</given-names></name>, <name><surname>Boutz</surname><given-names>DR</given-names></name>, <name><surname>Lavinder</surname><given-names>JJ</given-names></name>, <name><surname>Miklos</surname><given-names>AE</given-names></name>, <name><surname>Hughes</surname><given-names>RA</given-names></name>, <name><surname>Hoi</surname><given-names>KH</given-names></name>, <etal>et al</etal><article-title>Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2013</year>;<volume>110</volume>(<issue>8</issue>):<fpage>2993</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1213737110</pub-id> .<?supplied-pmid 23382245?><pub-id pub-id-type="pmid">23382245</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>Kunik</surname><given-names>V</given-names></name>, <name><surname>Peters</surname><given-names>B</given-names></name>, <name><surname>Ofran</surname><given-names>Y</given-names></name>. <article-title>Structural consensus among antibodies defines the antigen binding site</article-title>. <source>PLoS Computational Biology</source>. <year>2012</year>;<volume>8</volume>(<issue>2</issue>):<fpage>e1002388</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1002388</pub-id> .<?supplied-pmid 22383868?><pub-id pub-id-type="pmid">22383868</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Greiff</surname><given-names>V</given-names></name>, <name><surname>Menzel</surname><given-names>U</given-names></name>, <name><surname>Haessler</surname><given-names>U</given-names></name>, <name><surname>Cook</surname><given-names>SC</given-names></name>, <name><surname>Friedensohn</surname><given-names>S</given-names></name>, <name><surname>Khan</surname><given-names>TA</given-names></name>, <etal>et al</etal><article-title>Quantitative assessment of the robustness of next-generation sequencing of antibody variable gene repertoires from immunized mice</article-title>. <source>BMC immunology</source>. <year>2014</year>;<volume>15</volume>(<issue>1</issue>):<fpage>40</fpage><pub-id pub-id-type="doi">10.1186/s12865-014-0040-5</pub-id> .<?supplied-pmid 25318652?><pub-id pub-id-type="pmid">25318652</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Georgiou</surname><given-names>G</given-names></name>, <name><surname>Ippolito</surname><given-names>GC</given-names></name>, <name><surname>Beausang</surname><given-names>J</given-names></name>, <name><surname>Busse</surname><given-names>CE</given-names></name>, <name><surname>Wardemann</surname><given-names>H</given-names></name>, <name><surname>Quake</surname><given-names>SR</given-names></name>. <article-title>The promise and challenge of high-throughput sequencing of the antibody repertoire</article-title>. <source>Nature biotechnology</source>. <year>2014</year>;<volume>32</volume>(<issue>2</issue>):<fpage>158</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.2782</pub-id> .<?supplied-pmid 24441474?><pub-id pub-id-type="pmid">24441474</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref006">
      <label>6</label>
      <mixed-citation publication-type="journal"><name><surname>Avram</surname><given-names>O</given-names></name>, <name><surname>Vaisman-Mentesh</surname><given-names>A</given-names></name>, <name><surname>Yehezkel</surname><given-names>D</given-names></name>, <name><surname>Ashkenazy</surname><given-names>H</given-names></name>, <name><surname>Pupko</surname><given-names>T</given-names></name>, <name><surname>Wine</surname><given-names>Y</given-names></name>. <article-title>ASAP, A Webserver for Immunoglobulin-Sequencing Analysis Pipeline</article-title>. <source>Frontiers in Immunology</source>. <year>2018</year>;<volume>9</volume><pub-id pub-id-type="doi">10.3389/fimmu.2018.01686</pub-id> .<?supplied-pmid 30105017?><pub-id pub-id-type="pmid">30105017</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><name><surname>Smakaj</surname><given-names>E</given-names></name>, <name><surname>Babrak</surname><given-names>L</given-names></name>, <name><surname>Ohlin</surname><given-names>M</given-names></name>, <name><surname>Shugay</surname><given-names>M</given-names></name>, <name><surname>Briney</surname><given-names>B</given-names></name>, <name><surname>Tosoni</surname><given-names>D</given-names></name>, <etal>et al</etal><article-title>Benchmarking immunoinformatic tools for the analysis of antibody repertoire sequences</article-title>. <source>Bioinformatics</source>. <year>2020</year>;<volume>36</volume>(<issue>6</issue>):<fpage>1731</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btz845</pub-id> .<?supplied-pmid 31873728?><pub-id pub-id-type="pmid">31873728</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref008">
      <label>8</label>
      <mixed-citation publication-type="journal"><name><surname>Breden</surname><given-names>F</given-names></name>, <name><surname>Luning Prak</surname><given-names>ET</given-names></name>, <name><surname>Peters</surname><given-names>B</given-names></name>, <name><surname>Rubelt</surname><given-names>F</given-names></name>, <name><surname>Schramm</surname><given-names>CA</given-names></name>, <name><surname>Busse</surname><given-names>CE</given-names></name>, <etal>et al</etal><article-title>Reproducibility and Reuse of Adaptive Immune Receptor Repertoire Data</article-title>. <source>Frontiers in Immunology</source>. <year>2017</year>;<volume>8</volume>:<fpage>1418</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.01418</pub-id> .<?supplied-pmid 29163494?><pub-id pub-id-type="pmid">29163494</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref009">
      <label>9</label>
      <mixed-citation publication-type="journal"><name><surname>Wine</surname><given-names>Y</given-names></name>, <name><surname>Horton</surname><given-names>AP</given-names></name>, <name><surname>Ippolito</surname><given-names>GC</given-names></name>, <name><surname>Georgiou</surname><given-names>G</given-names></name>. <article-title>Serology in the 21st century: the molecular-level analysis of the serum antibody repertoire</article-title>. <source>Current Opinion in Immunology</source>. <year>2015</year>;<volume>35</volume>:<fpage>89</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2015.06.009</pub-id> .<?supplied-pmid 26172290?><pub-id pub-id-type="pmid">26172290</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref010">
      <label>10</label>
      <mixed-citation publication-type="journal"><name><surname>Lavinder</surname><given-names>JJ</given-names></name>, <name><surname>Wine</surname><given-names>Y</given-names></name>, <name><surname>Giesecke</surname><given-names>C</given-names></name>, <name><surname>Ippolito</surname><given-names>GC</given-names></name>, <name><surname>Horton</surname><given-names>AP</given-names></name>, <name><surname>Lungu</surname><given-names>OI</given-names></name>, <etal>et al</etal><article-title>Identification and characterization of the constituent human serum antibodies elicited by vaccination</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2014</year>;<volume>111</volume>(<issue>6</issue>):<fpage>2259</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1317793111</pub-id> .<?supplied-pmid 24469811?><pub-id pub-id-type="pmid">24469811</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref011">
      <label>11</label>
      <mixed-citation publication-type="journal"><name><surname>Boutz</surname><given-names>DR</given-names></name>, <name><surname>Horton</surname><given-names>AP</given-names></name>, <name><surname>Wine</surname><given-names>Y</given-names></name>, <name><surname>Lavinder</surname><given-names>JJ</given-names></name>, <name><surname>Georgiou</surname><given-names>G</given-names></name>, <name><surname>Marcotte</surname><given-names>EM</given-names></name>. <article-title>Proteomic Identification of Monoclonal Antibodies from Serum</article-title>. <source>Analytical Chemistry</source>. <year>2014</year>;<volume>86</volume>(<issue>10</issue>):<fpage>4758</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1021/ac4037679</pub-id> .<?supplied-pmid 24684310?><pub-id pub-id-type="pmid">24684310</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Iversen</surname><given-names>R</given-names></name>, <name><surname>Snir</surname><given-names>O</given-names></name>, <name><surname>Stensland</surname><given-names>M</given-names></name>, <name><surname>Kroll</surname><given-names>JE</given-names></name>, <name><surname>Steinsbø</surname><given-names>Ø</given-names></name>, <name><surname>Korponay-Szabó</surname><given-names>IR</given-names></name>, <etal>et al</etal><article-title>Strong Clonal Relatedness between Serum and Gut IgA despite Different Plasma Cell Origins</article-title>. <source>Cell Rep</source>. <year>2017</year>;<volume>20</volume>(<issue>10</issue>):<fpage>2357</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.08.036</pub-id> .<?supplied-pmid 28877470?><pub-id pub-id-type="pmid">28877470</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Tipton</surname><given-names>CM</given-names></name>, <name><surname>Fucile</surname><given-names>CF</given-names></name>, <name><surname>Darce</surname><given-names>J</given-names></name>, <name><surname>Chida</surname><given-names>A</given-names></name>, <name><surname>Ichikawa</surname><given-names>T</given-names></name>, <name><surname>Gregoretti</surname><given-names>I</given-names></name>, <etal>et al</etal><article-title>Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus</article-title>. <source>Nature Immunology</source>. <year>2015</year>;<volume>16</volume>(<issue>7</issue>):<fpage>755</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3175</pub-id> .<?supplied-pmid 26006014?><pub-id pub-id-type="pmid">26006014</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref014">
      <label>14</label>
      <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>J</given-names></name>, <name><surname>Boutz</surname><given-names>DR</given-names></name>, <name><surname>Chromikova</surname><given-names>V</given-names></name>, <name><surname>Joyce</surname><given-names>MG</given-names></name>, <name><surname>Vollmers</surname><given-names>C</given-names></name>, <name><surname>Leung</surname><given-names>K</given-names></name>, <etal>et al</etal><article-title>Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination</article-title>. <source>Nature Medicine</source>. <year>2016</year>;<volume>22</volume>(<issue>12</issue>):<fpage>1456</fpage>–<lpage>64</lpage><pub-id pub-id-type="doi">10.1038/nm.4224</pub-id> .<?supplied-pmid 27820605?><pub-id pub-id-type="pmid">27820605</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref015">
      <label>15</label>
      <mixed-citation publication-type="journal"><name><surname>Vaisman-Mentesh</surname><given-names>A</given-names></name>, <name><surname>Rosenstein</surname><given-names>S</given-names></name>, <name><surname>Yavzori</surname><given-names>M</given-names></name>, <name><surname>Dror</surname><given-names>Y</given-names></name>, <name><surname>Fudim</surname><given-names>E</given-names></name>, <name><surname>Ungar</surname><given-names>B</given-names></name>, <etal>et al</etal><article-title>Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFalpha Antagonists</article-title>. <source>Front Immunol</source>. <year>2019</year>;<volume>10</volume>:<fpage>2921</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.02921</pub-id> .<?supplied-pmid 31921180?><pub-id pub-id-type="pmid">31921180</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref016">
      <label>16</label>
      <mixed-citation publication-type="journal"><name><surname>Lindesmith</surname><given-names>LC</given-names></name>, <name><surname>McDaniel</surname><given-names>JR</given-names></name>, <name><surname>Changela</surname><given-names>A</given-names></name>, <name><surname>Verardi</surname><given-names>R</given-names></name>, <name><surname>Kerr</surname><given-names>SA</given-names></name>, <name><surname>Costantini</surname><given-names>V</given-names></name>, <etal>et al</etal><article-title>Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic Strain Neutralizing Responses after Human Norovirus Vaccination</article-title>. <source>Immunity</source>. <year>2019</year>;<volume>50</volume>(<issue>6</issue>):<fpage>1530</fpage>–<lpage>41.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2019.05.007</pub-id> .<?supplied-pmid 31216462?><pub-id pub-id-type="pmid">31216462</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref017">
      <label>17</label>
      <mixed-citation publication-type="journal"><name><surname>McDaniel</surname><given-names>JR</given-names></name>, <name><surname>Pero</surname><given-names>SC</given-names></name>, <name><surname>Voss</surname><given-names>WN</given-names></name>, <name><surname>Shukla</surname><given-names>GS</given-names></name>, <name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Schaetzle</surname><given-names>S</given-names></name>, <etal>et al</etal><article-title>Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node</article-title>. <source>Cancer Immunology, Immunotherapy</source>. <year>2018</year>;<volume>67</volume>(<issue>5</issue>):<fpage>729</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1007/s00262-018-2123-2</pub-id> .<?supplied-pmid 29427082?><pub-id pub-id-type="pmid">29427082</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref018">
      <label>18</label>
      <mixed-citation publication-type="journal"><name><surname>Cox</surname><given-names>J</given-names></name>, <name><surname>Hein</surname><given-names>MY</given-names></name>, <name><surname>Luber</surname><given-names>CA</given-names></name>, <name><surname>Paron</surname><given-names>I</given-names></name>, <name><surname>Nagaraj</surname><given-names>N</given-names></name>, <name><surname>Mann</surname><given-names>M</given-names></name>. <article-title>Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ</article-title>. <source>Molecular &amp; cellular proteomics: MCP</source>. <year>2014</year>;<volume>13</volume>(<issue>9</issue>):<fpage>2513</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M113.031591</pub-id> .<?supplied-pmid 24942700?><pub-id pub-id-type="pmid">24942700</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1008607.ref019">
      <label>19</label>
      <mixed-citation publication-type="journal"><name><surname>Cox</surname><given-names>J</given-names></name>, <name><surname>Mann</surname><given-names>M</given-names></name>. <article-title>MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification</article-title>. <source>Nature biotechnology</source>. <year>2008</year>;<volume>26</volume>(<issue>12</issue>):<fpage>1367</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.1511</pub-id> .<?supplied-pmid 19029910?><pub-id pub-id-type="pmid">19029910</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<sub-article id="pcbi.1008607.r001" article-type="aggregated-review-documents">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1008607.r001</article-id>
    <title-group>
      <article-title>Decision Letter 0</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Pertea</surname>
          <given-names>Mihaela</given-names>
        </name>
        <role>Software Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2021 Mihaela Pertea</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Mihaela Pertea</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article id="rel-obj001" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1008607" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>0</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">24 Oct 2020</named-content>
    </p>
    <p>Dear Dr. Wine,</p>
    <p>Thank you very much for submitting your manuscript "PASA: proteomic analysis of serum antibodies web server" for consideration at PLOS Computational Biology.</p>
    <p>As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.</p>
    <p>We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.</p>
    <p>When you are ready to resubmit, please upload the following:</p>
    <p>[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.</p>
    <p>[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).</p>
    <p>Important additional instructions are given below your reviewer comments.</p>
    <p>Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.</p>
    <p>Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.</p>
    <p>Sincerely,</p>
    <p>Mihaela Pertea</p>
    <p>Software Editor</p>
    <p>PLOS Computational Biology</p>
    <p>Mihaela Pertea</p>
    <p>Software Editor</p>
    <p>PLOS Computational Biology</p>
    <p>***********************</p>
    <p>Reviewer's Responses to Questions</p>
    <p>
      <bold>Comments to the Authors:</bold>
    </p>
    <p>
      <bold>Please note here if the review is uploaded as an attachment.</bold>
    </p>
    <p>Reviewer #1: Summary: In this manuscript, Avram and Kigel and colleagues, report the implementation of the PASA web server that is stated to provide a robust computational platform for the analysis and integration of data obtained from proteomics of serum antibodies. Specifically, PASA enables the mapping of peptides derived from antibodies raised against a specific antigen to corresponding antibody sequences.</p>
    <p>Major</p>
    <p>Can the authors identify the maxquant version used and the specific maxquant parameters. Furthermore the maxquant parameters files should be provided in the output so that users may reproduce their findings in the future.</p>
    <p>Furthermore, the versatility of the webserver remains opaque to the reviewer. Can the webserver also be used if one does not have antigen-specific data? So, just a VDJ-database and MS/MS raw files?</p>
    <p>Can the authors provide runtime analyses for common file sizes?</p>
    <p>Why is there no command line version which would enable parallelization etc?</p>
    <p>What is the novelty of the PASA tool? Have you gained any biological insights using PASA?</p>
    <p>Minor</p>
    <p>Line 45: please provide original references for the statement that the CDR3H contributes most to antigen binding (for example Xu et al., 2000, Immunity (last author: Mark Davis)).</p>
    <p>Line 46: Please provide a reference for the statement: CDRH3 is often used as a unique identifier to determine antibody clonality</p>
    <p><ext-link ext-link-type="uri" xlink:href="https://pasa.tau.ac.il/gallery.html">https://pasa.tau.ac.il/gallery.html</ext-link>: color scheme for the Isotype Distribution pie chart is not color blind friendly</p>
    <p><ext-link ext-link-type="uri" xlink:href="https://pasa.tau.ac.il/gallery.html">https://pasa.tau.ac.il/gallery.html</ext-link>: the y-axis “% of total” Percent of total what? All the peptides or ig-related peptides?</p>
    <p><ext-link ext-link-type="uri" xlink:href="https://pasa.tau.ac.il/index.html">https://pasa.tau.ac.il/index.html</ext-link> BCR-Seq DB tooltip: link to the ASAP format goes to the same (index.html) page</p>
    <p><ext-link ext-link-type="uri" xlink:href="https://pasa.tau.ac.il/index.html">https://pasa.tau.ac.il/index.html</ext-link>: “Please notice that since the raw files are (very) heavy.” — English?</p>
    <p>Line 92: “Proteomics intensity with respect to each BCR-seq database intensity” — what does BCR-seq database intensity mean?</p>
    <p>Reviewer #2: Wine et al. present PASA (proteomic analysis of serum antibodies) a web server for proteomic antibody repertoire analysis. Presumably the server was designed for human samples -no information is provided on whether it might work for antibody repertoires from other species. PASA is very user friendly and enables to process and assign proteomic data using a specimen specific V gene data base. This is a tool that is likely to be very useful for the community and publication is recommended. I wish the V gene DNA sequence was more versatile (only data in ASAP is accepted) but that is a minor complaints.</p>
    <p>The manuscript is very well written and to the point.</p>
    <p>**********</p>
    <p>
      <bold>Have all data underlying the figures and results presented in the manuscript been provided?</bold>
    </p>
    <p>Large-scale datasets should be made available via a public repository as described in the <italic>PLOS Computational Biology</italic>
<ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/ploscompbiol/s/data-availability">data availability policy</ext-link>, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.</p>
    <p>Reviewer #1: <bold>No: </bold>maxquant parameters file should be provided with the output</p>
    <p>Reviewer #2: Yes</p>
    <p>**********</p>
    <p>PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
    <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
    <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy">Privacy Policy</ext-link>.</p>
    <p>Reviewer #1: No</p>
    <p>Reviewer #2: No</p>
    <p>
      <underline>Figure Files:</underline>
    </p>
    <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <underline><ext-link ext-link-type="uri" xlink:href="https://pacev2.apexcovantage.com/" xlink:type="simple">https://pacev2.apexcovantage.com</ext-link></underline>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <underline><email xlink:type="simple">figures@plos.org</email></underline>.</p>
    <p>
      <underline>Data Requirements:</underline>
    </p>
    <p>Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: <ext-link ext-link-type="uri" xlink:href="http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5">http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5</ext-link>.</p>
    <p>
      <underline>Reproducibility:</underline>
    </p>
    <p>To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions, please see <underline><ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plospathogens/s/submission-guidelines" xlink:type="simple">http://journals.plos.org/compbiol/s/submission-guidelines#loc-materials-and-methods</ext-link></underline></p>
  </body>
</sub-article>
<sub-article id="pcbi.1008607.r002" article-type="author-comment">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1008607.r002</article-id>
    <title-group>
      <article-title>Author response to Decision Letter 0</article-title>
    </title-group>
    <related-article id="rel-obj002" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1008607" related-article-type="editor-report"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>1</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="author-response-date">3 Nov 2020</named-content>
    </p>
    <supplementary-material content-type="local-data" id="pcbi.1008607.s001">
      <label>Attachment</label>
      <caption>
        <p>Submitted filename: <named-content content-type="submitted-filename">PASA_V7_point_by_point_letter.docx</named-content></p>
      </caption>
      <media xlink:href="pcbi.1008607.s001.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </body>
</sub-article>
<sub-article id="pcbi.1008607.r003" article-type="aggregated-review-documents">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1008607.r003</article-id>
    <title-group>
      <article-title>Decision Letter 1</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Pertea</surname>
          <given-names>Mihaela</given-names>
        </name>
        <role>Software Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2021 Mihaela Pertea</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Mihaela Pertea</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article id="rel-obj003" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1008607" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>1</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">6 Dec 2020</named-content>
    </p>
    <p>Dear Dr. Wine,</p>
    <p>We are pleased to inform you that your manuscript 'PASA: Proteomic Analysis of Serum Antibodies web server' has been provisionally accepted for publication in PLOS Computational Biology.</p>
    <p>Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.</p>
    <p>Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.</p>
    <p>IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.</p>
    <p>Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.</p>
    <p>Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. </p>
    <p>Best regards,</p>
    <p>Mihaela Pertea</p>
    <p>Software Editor</p>
    <p>PLOS Computational Biology</p>
    <p>Mihaela Pertea</p>
    <p>Software Editor</p>
    <p>PLOS Computational Biology</p>
    <p>***********************************************************</p>
    <p>Reviewer's Responses to Questions</p>
    <p>
      <bold>Comments to the Authors:</bold>
    </p>
    <p>
      <bold>Please note here if the review is uploaded as an attachment.</bold>
    </p>
    <p>Reviewer #1: The authors have addressed all reviewer concerns.</p>
    <p>**********</p>
    <p>
      <bold>Have all data underlying the figures and results presented in the manuscript been provided?</bold>
    </p>
    <p>Large-scale datasets should be made available via a public repository as described in the <italic>PLOS Computational Biology</italic>
<ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/ploscompbiol/s/data-availability">data availability policy</ext-link>, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.</p>
    <p>Reviewer #1: Yes</p>
    <p>**********</p>
    <p>PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
    <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
    <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy">Privacy Policy</ext-link>.</p>
    <p>Reviewer #1: No</p>
  </body>
</sub-article>
<sub-article id="pcbi.1008607.r004" article-type="editor-report">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1008607.r004</article-id>
    <title-group>
      <article-title>Acceptance letter</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Pertea</surname>
          <given-names>Mihaela</given-names>
        </name>
        <role>Software Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2021 Mihaela Pertea</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Mihaela Pertea</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article id="rel-obj004" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1008607" related-article-type="reviewed-article"/>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">21 Jan 2021</named-content>
    </p>
    <p>PCOMPBIOL-D-20-01304R1 </p>
    <p>PASA: Proteomic Analysis of Serum Antibodies web server</p>
    <p>Dear Dr Wine,</p>
    <p>I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.</p>
    <p>The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. </p>
    <p>Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.</p>
    <p>Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work! </p>
    <p>With kind regards,</p>
    <p>Jutka Oroszlan</p>
    <p>PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom <email>ploscompbiol@plos.org</email> | Phone +44 (0) 1223-442824 | <ext-link ext-link-type="uri" xlink:href="http://ploscompbiol.org">ploscompbiol.org</ext-link> | @PLOSCompBiol</p>
  </body>
</sub-article>
